Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Clinical trials news

Show

From To
'Give HIV drugs to healthy gay men'

Healthy gay men should be offered daily HIV drugs to prevent infections, say UK Medical Research Council and Public Health England scientists. Their study, on 545 high-risk men, found one case of HIV could be stopped for every 13 men treated for a year. The research team says it would be similar to the pill for women and would not encourage risky sex. The findings have been described as a "game changer" and the NHS is considering how to adopt them.

Published
25 February 2015
From
BBC News
The Search for a Permanent Alternative to HIV Drugs

Researchers Carefully Tailor a Study to Find Patients to Test Going Off Antiretroviral Medication

Published
16 February 2015
From
Wall Street Journal
VOICE trial: Microbicide gel may have stopped two out of three HIV infections – in the women who used it

The final published paper on the VOICE trial in women in three African countries mainly reinforces what conference presentations have already shown: this ambitious trial failed to

Published
09 February 2015
By
Gus Cairns
Failed Trial in Africa Raises Questions About How to Test HIV Drugs

The failure of the VOICE trial of H.I.V.-prevention methods in Africa — and the elaborate deceptions employed by the women in it — have opened an ethical debate about how to run such studies in poor countries and have already changed the design of some that are now underway.

Published
05 February 2015
From
New York Times
New anti HIV drug dolutegravir is effective at low doses

The new anti-HIV integrase inhibitor dolutegravir is a highly potent drug. Alain Lafeuillade, a clinical researcher for 20 years in HIV disease, observed that Dolutegravir is highly effective alone in patients without integrase resistance. "Plasma viral load remained undetectable in my patients, and proviral HIV DNA in cells remained stable with only 50 mg 2 to 3 times a week," he said. He is proposing a low-dose dolutegravir monotherapy trial.

Published
21 January 2015
From
MMD Newswire
Gay men are better at predicting when they won’t have sex than when they will

A study in which a group of HIV-negative gay and bisexual men from New York were asked to predict each day whether they would have sex the

Published
12 January 2015
By
Gus Cairns
Pressure grows for Europe to subsidize HIV prevention drug Truvada

HIV-AIDS organizations are urging European health authorities to approve and subsidize the use of HIV prevention drug Truvada as infections slowly rise across the continent.

Published
02 December 2014
From
Deutsche Welle
START Study Could Change How We Look at HIV Treatment, and HIV Itself

Have you heard of the START (Strategic Timing of Antiretroviral Treatment) study? In my opinion, it is probably the most important study currently running. It generates strong views, both for and against initiating antiretroviral therapy early, but the results are likely to be surprising.

Published
25 November 2014
From
The Body
Groundbreaking HIV vaccine's effects were real – and could be made to work better

Findings from further studies using a reformulation of the only HIV vaccine that has ever worked in a large efficacy trial were presented at the recent HIV

Published
13 November 2014
By
Gus Cairns
What are the barriers that could stop HIV treatment becoming HIV prevention?

One of the key strategies involved in trying to bring an end to the HIV epidemic is to increase the proportion of HIV-positive people on antiretroviral therapy

Published
12 November 2014
By
Gus Cairns
← First12345...13Next →

Filter by country